The Economic Burden of Relapse in Acute Myeloid Leukemia (AML): A Retrospective Analysis of US Commercial and Medicare Claims
Publication
, Conference
Tabah, A; Huggar, D; Brady, BL; Jariwala-Parikh, K; Huey, K; Copher, RM; Leblanc, TW
Published in: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
2020
Duke Scholars
Published In
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
EISSN
2152-2669
ISSN
2152-2650
Publication Date
2020
Volume
20
Start / End Page
S181 / S181
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3201 Cardiovascular medicine and haematology
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Tabah, A., Huggar, D., Brady, B. L., Jariwala-Parikh, K., Huey, K., Copher, R. M., & Leblanc, T. W. (2020). The Economic Burden of Relapse in Acute Myeloid Leukemia (AML): A Retrospective Analysis of US Commercial and Medicare Claims. In CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (Vol. 20, pp. S181–S181).
Tabah, Ashley, David Huggar, Brenna L. Brady, Krutika Jariwala-Parikh, Krystal Huey, Ronda M. Copher, and Thomas W. Leblanc. “The Economic Burden of Relapse in Acute Myeloid Leukemia (AML): A Retrospective Analysis of US Commercial and Medicare Claims.” In CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 20:S181–S181, 2020.
Tabah A, Huggar D, Brady BL, Jariwala-Parikh K, Huey K, Copher RM, et al. The Economic Burden of Relapse in Acute Myeloid Leukemia (AML): A Retrospective Analysis of US Commercial and Medicare Claims. In: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2020. p. S181–S181.
Tabah, Ashley, et al. “The Economic Burden of Relapse in Acute Myeloid Leukemia (AML): A Retrospective Analysis of US Commercial and Medicare Claims.” CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol. 20, 2020, pp. S181–S181.
Tabah A, Huggar D, Brady BL, Jariwala-Parikh K, Huey K, Copher RM, Leblanc TW. The Economic Burden of Relapse in Acute Myeloid Leukemia (AML): A Retrospective Analysis of US Commercial and Medicare Claims. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2020. p. S181–S181.
Published In
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
EISSN
2152-2669
ISSN
2152-2650
Publication Date
2020
Volume
20
Start / End Page
S181 / S181
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3201 Cardiovascular medicine and haematology
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences